Transient hypofibrinogenemia due to allopurinol

Drug Des Devel Ther. 2014 Sep 2:8:1231-3. doi: 10.2147/DDDT.S66868. eCollection 2014.

Abstract

This study reports a case of an 80-year-old male who suffered from drug eruption due to oral allopurinol for the treatment of gout. This patient complained of widespread erythema and maculopapule with itch, and small quantities of purplish-red rash with diffused distribution on four limbs were noted. After he was hospitalized, the area with purpuric rash increased in size, and hypofibrinogenemia was found. After treatment with intravenous infusion of fibrinogen and cryoprecipitate, and continued treatment with high-dose methylprednisolone, the skin rash gradually went away. This is the first report of purpura and hypofibrinogenemia induced by allopurinol and the pathophysiology underlying this reaction remained unknown.

Keywords: drug eruption; fibrinogen; gout; purpura.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Afibrinogenemia / drug therapy*
  • Afibrinogenemia / pathology
  • Aged, 80 and over
  • Allopurinol / administration & dosage
  • Allopurinol / adverse effects*
  • Drug Eruptions
  • Fibrinogen / administration & dosage
  • Humans
  • Infusions, Intravenous
  • Male
  • Methylprednisolone / administration & dosage

Substances

  • Allopurinol
  • Fibrinogen
  • Methylprednisolone